603 related articles for article (PubMed ID: 28814338)
1. Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.
Kenward H; Elliott J; Lee T; Pelligand L
BMC Vet Res; 2017 Aug; 13(1):244. PubMed ID: 28814338
[TBL] [Abstract][Full Text] [Related]
2. Prospective, controlled, blinded, randomized crossover trial evaluating the effect of maropitant versus ondansetron on inhibiting tranexamic acid-evoked emesis.
Kantyka ME; Meira C; Bettschart-Wolfensberger R; Hartnack S; Kutter APN
J Vet Emerg Crit Care (San Antonio); 2020 Jul; 30(4):436-441. PubMed ID: 32515910
[TBL] [Abstract][Full Text] [Related]
3. Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study.
Henze L; Foth S; Meller S; Twele F; Charalambous M; Kenward H; Elliott J; Pelligand L; Volk HA
J Vet Intern Med; 2022 Sep; 36(5):1726-1732. PubMed ID: 35906792
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs.
Yalcin E; Keser GO
J Vet Pharmacol Ther; 2017 Dec; 40(6):599-603. PubMed ID: 28198032
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs.
Sedlacek HS; Ramsey DS; Boucher JF; Eagleson JS; Conder GA; Clemence RG
J Vet Pharmacol Ther; 2008 Dec; 31(6):533-7. PubMed ID: 19000276
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blinded, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high-dose cisplatin in medical practice.
Ithimakin S; Runglodvatana K; Nimmannit A; Akewanlop C; Srimuninnimit V; Keerativitayanan N; Soparattanapaisarn N; Laocharoenkeat A
Support Care Cancer; 2012 Apr; 20(4):849-55. PubMed ID: 21505898
[TBL] [Abstract][Full Text] [Related]
7. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
[TBL] [Abstract][Full Text] [Related]
8. A comparison between maropitant and metoclopramide for the prevention of morphine-induced nausea and vomiting in dogs.
Lorenzutti AM; Martín-Flores M; Litterio NJ; Himelfarb MA; Invaldi SH; Zarazaga MP
Can Vet J; 2017 Jan; 58(1):35-38. PubMed ID: 28042152
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of orally administered maropitant and ondansetron in preventing preoperative emesis and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate.
Burke JE; Hess RS; Silverstein DC
J Am Vet Med Assoc; 2021 Dec; 260(S1):S40-S45. PubMed ID: 34914630
[TBL] [Abstract][Full Text] [Related]
10. Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2004 Sep; 120(3):183-93. PubMed ID: 15489556
[TBL] [Abstract][Full Text] [Related]
11. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
Hainsworth J; Harvey W; Pendergrass K; Kasimis B; Oblon D; Monaghan G; Gandara D; Hesketh P; Khojasteh A; Harker G
J Clin Oncol; 1991 May; 9(5):721-8. PubMed ID: 1826739
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.
Bhatia A; Tripathi KD; Sharma M
Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464
[TBL] [Abstract][Full Text] [Related]
13. In vivo assessment of antiemetic drugs and mechanism of lycorine-induced nausea and emesis.
Kretzing S; Abraham G; Seiwert B; Ungemach FR; Krügel U; Teichert J; Regenthal R
Arch Toxicol; 2011 Dec; 85(12):1565-73. PubMed ID: 21626407
[TBL] [Abstract][Full Text] [Related]
14. Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.
De Mulder PH; Seynaeve C; Vermorken JB; van Liessum PA; Mols-Jevdevic S; Allman EL; Beranek P; Verweij J
Ann Intern Med; 1990 Dec; 113(11):834-40. PubMed ID: 2146911
[TBL] [Abstract][Full Text] [Related]
15. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination.
Roila F
Oncology; 1993; 50(3):163-7. PubMed ID: 8459986
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.
Marty M; Pouillart P; Scholl S; Droz JP; Azab M; Brion N; Pujade-Lauraine E; Paule B; Paes D; Bons J
N Engl J Med; 1990 Mar; 322(12):816-21. PubMed ID: 2137902
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs.
de la Puente-Redondo VA; Tilt N; Rowan TG; Clemence RG
Am J Vet Res; 2007 Jan; 68(1):48-56. PubMed ID: 17199418
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study.
Köseoglu V; Kürekçi AE; Sarici U; Atay AA; Ozcan O
Eur J Pediatr; 1998 Oct; 157(10):806-10. PubMed ID: 9809818
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study.
Gebbia V; Testa A; Cannata G; Gebbia N
Anticancer Drugs; 1996 Sep; 7(7):734-7. PubMed ID: 8949983
[TBL] [Abstract][Full Text] [Related]
20. Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research.
J Clin Oncol; 1993 Dec; 11(12):2396-404. PubMed ID: 8246029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
